Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anoop Misra

Showing results (71-80 of 410) with videos related to

Pageof 41
Sort By:
The Lancet. Diabetes & Endocrinology|January 3, 2016
Drug approvals in India - Authors' replyAtul Luthra, Anoop Misra
Journal of Diabetes|November 2, 2017
Metabolic memory: Evolving conceptsAnoop Misra, Zachary Bloomgarden
The National Medical Journal of India|May 31, 2018
The topoisomerase 'poisons'Anoop Misra, Pankaj Gupta
Metabolic Syndrome and Related Disorders|November 11, 2009
The metabolic syndrome in South Asians: epidemiology, determinants, and preventionAnoop Misra, Lokesh Khurana
Diabetes & Metabolic Syndrome|May 11, 2020
Editorial: Herd mentality, herds of migrants/people, and COVID-19 in IndiaAwadhesh Kumar Singh, Anoop Misra
The Indian Journal of Medical Research|June 26, 2008
Factors, definitions, predictive value & Asian Indian ethnicity: complexities of the metabolic syndromeAnoop Misra, Naval K Vikram
Diabetes & Metabolic Syndrome|September 5, 2020
Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and IndiaAwadhesh Kumar Singh, Anoop Misra
Diabetes & Metabolic Syndrome|May 23, 2020
From non-alcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD): A journey over 40 yearsMohammad Shafi Kuchay, Anoop Misra
Diabetes & Metabolic Syndrome|March 8, 2022
Role of diabetologists in the management of nonalcoholic fatty liver disease: Primary prevention and screening/management of fibrosis and cirrhosisMohammad Shafi Kuchay, Anoop Misra
Diabetes & Metabolic Syndrome|August 3, 2022
Sodium-glucose cotransporter-2 inhibitors as first-line pharmacological therapy for type 2 diabetes?Mohammad Shafi Kuchay, Anoop Misra
Pageof 41

Showing results (71-80 of 410) with videos related to

Sort By:
Pageof 41
The Lancet. Diabetes & Endocrinology|January 3, 2016
Drug approvals in India - Authors' replyAtul Luthra, Anoop Misra
Journal of Diabetes|November 2, 2017
Metabolic memory: Evolving conceptsAnoop Misra, Zachary Bloomgarden
The National Medical Journal of India|May 31, 2018
The topoisomerase 'poisons'Anoop Misra, Pankaj Gupta
Metabolic Syndrome and Related Disorders|November 11, 2009
The metabolic syndrome in South Asians: epidemiology, determinants, and preventionAnoop Misra, Lokesh Khurana
Diabetes & Metabolic Syndrome|May 11, 2020
Editorial: Herd mentality, herds of migrants/people, and COVID-19 in IndiaAwadhesh Kumar Singh, Anoop Misra
The Indian Journal of Medical Research|June 26, 2008
Factors, definitions, predictive value & Asian Indian ethnicity: complexities of the metabolic syndromeAnoop Misra, Naval K Vikram
Diabetes & Metabolic Syndrome|September 5, 2020
Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and IndiaAwadhesh Kumar Singh, Anoop Misra
Diabetes & Metabolic Syndrome|May 23, 2020
From non-alcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD): A journey over 40 yearsMohammad Shafi Kuchay, Anoop Misra
Diabetes & Metabolic Syndrome|March 8, 2022
Role of diabetologists in the management of nonalcoholic fatty liver disease: Primary prevention and screening/management of fibrosis and cirrhosisMohammad Shafi Kuchay, Anoop Misra
Diabetes & Metabolic Syndrome|August 3, 2022
Sodium-glucose cotransporter-2 inhibitors as first-line pharmacological therapy for type 2 diabetes?Mohammad Shafi Kuchay, Anoop Misra
Pageof 41